The primary defect in experimental ileitis originates from a nonhematopoietic source

Journal of Experimental Medicine

Volumn 203, Issue 3, 2006, Pages 541-552

  Olson, Timothy S ^a,b   Reuter, Brian K ^a   Scott, Kevin G E ^a   Morris, Margaret A ^a,b   Wang, Xiao Ming ^a   Hancock, Leslie N ^a   Burcin, Tracy L ^a,b   Cohn, Steven M ^a   Ernst, Peter B ^a   Cominelli, Fabio ^a   Meddings, Jonathan B ^c   Ley, Klaus ^a,b   Pizarro, Theresa T ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 2; CYTOKINE; MESSENGER RNA; OCCLUDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENTERITIS; EX VIVO STUDY; EXTRAMEDULLARY HEMATOPOIESIS; GERMFREE ANIMAL; ILEITIS; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; INFLAMMATORY INFILTRATE; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOUSE; MUCOSAL IMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES COMPARISON; TIGHT JUNCTION; WILD TYPE;

ANIMALS; BACTERIA; BONE MARROW TRANSPLANTATION; CELL MEMBRANE PERMEABILITY; CROHN DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIUM; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMANS; ILEITIS; INFLAMMATION; LYMPHOCYTES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC;

EID: 33645049332     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20050407     Document Type: Article

References (54)

1. Bouma, G., and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3:521-533.
2. Egan, L.J., and W.J. Sandborn. 2004. Advances in the treatment of Crohn's disease. Gastroenterology. 126:1574-1581.
3. Ma, T.Y. 1997. Intestinal epithelial barrier dysfunction in Crohn's disease. Proc. Soc. Exp. Biol. Med. 214:318-327.
4. Shanahan, F. 2002. Crohn's disease. Lancet. 359:62-69.
5. Ogura, Y., N. Inohara, A. Benito, F.F. Chen, S. Yamaoka, and G. Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276:4812-4818.
6. Hisamatsu, T., M. Suzuki, H.C. Reinecker, W.J. Nadeau, B.A. McCormick, and D.K. Podolsky. 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 124:993-1000.
7. Monteleone, G., L. Biancone, R. Marasco, G. Morrone, O. Marasco, F. Luzza, and F. Pallone. 1997. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology. 112:1169-1178.
8. Fuss, I.J., M. Neurath, M. Boirivant, J.S. Klein, C. de la Mott, S.A. Strong, C. Fiocchi, and W. Strober. 1996. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157:1261-1270.
9. Mottet, C., H.H. Uhlig, and F. Powrie. 2003. Cutting edge: cure of colitis by CD4(+)CD25(+) regulatory T cells. J. Immunol. 170:3939-3943.
10. Powrie, F., M.W. Leach, S. Mauze, L.B. Caddle, and R.L. Coffman. 1993. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5:1461-1471.
11. Singh, B., S. Read, C. Asseman, V. Malmstrom, C. Mottet, L.A. Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie. 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:190-200.
12. Kraus, T.A., L. Toy, L. Chan, J. Childs, and L. Mayer. 2004. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology. 126:1771-1778.
13. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K.H. Meyer zum Buschenfelde. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102:448-455.
14. Kazemi-Shirazi, L., C.H. Gasche, S. Natter, A. Gangl, J. Smolen, S. Spitzauer, P. Valent, D. Kraft, and R. Valenta. 2002. IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases. Clin. Exp. Immunol. 128:102-109.
15. Dohi, T., K. Fujihashi, T. Koga, Y. Shirai, Y.I. Kawamura, C. Ejima, R. Kato, K. Saitoh, and J.R. McGhee. 2003. T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice. Gastroenterology. 124:672-682.
16. Dieckgraefe, B.K., and J.R. Korzenik. 2002. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet. 360:1478-1480.
17. Lopez-Cubero, S.O., K.M. Sullivan, and G.B. McDonald. 1998. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology. 114:433-440.
18. Cario, E., and D.K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68:7010-7017.
19. Pizarro, T.T., M.H. Michie, M. Bentz, J. Woraratanadharm, M.F. Smith Jr., E. Foley, C.A. Moskaluk, S.J. Bickston, and F. Cominelli. 1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 162:6829-6835.
20. Dwinell, M.B., P.A. Johanesen, and J.M. Smith. 2003. Immunobiology of epithelial chemokines in the intestinal mucosa. Surgery. 133:601-607.
21. Meddings, J. 2000. Barrier dysfunction and Crohn's disease. Ann. NY Acad. Sci. 915:333-338.
22. Hollander, D., C.M. Vadheim, E. Brettholz, G.M. Petersen, T. Delahunty, and J.I. Rotter. 1986. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 105:883-885.
23. May, G.R., L.R. Sutherland, and J.B. Meddings. 1993. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology. 104:1627-1632.
24. Wyatt, J., H. Vogelsang, W. Hubl, T. Waldhoer, and H. Lochs. 1993. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet. 341:1437-1439.
25. Schneeberger, E.E., and R.D. Lynch. 2004. The tight junction: a multifunctional complex. Am. J. Physiol. Cell Physiol. 286:C1213-C1228.
26. Gewirtz, A.T., Y. Liu, S.V. Sitaraman, and J.L. Madara. 2002. Intestinal epithelial pathobiology: past, present and future. Best Pract. Res. Clin. Gastroenterol. 16:851-867.
27. Clayburgh, D.R., L. Shen, and J.R. Turner. 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84:282-291.
28. Furuse, M., K. Furuse, H. Sasaki, and S. Tsukita. 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 153:263-272.
29. Turksen, K., and T.C. Troy. 2004. Barriers built on claudins. J. Cell Sci. 117:2435-2447.
30. Simonovic, I., J. Rosenberg, A. Koutsouris, and G. Hecht. 2000. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell. Microbiol. 2:305-315.
31. Ma, T.Y., G.K. Iwamoto, N.T. Hoa, V. Akotia, A. Pedram, M.A. Boivin, and H.M. Said. 2004. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286:G367-G376.
32. Strober, W., I.J. Fuss, and R.S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20:495-549.
33. Crohn, B.B., L. Ginzburg, and G.D. Oppenheimer. 1932. Regional ileitis: a pathologic and clinical entity. 1932. Mt. Sinai J. Med. 99:1323-1329.
34. Matsumoto, S., Y. Okabe, H. Setoyama, K. Takayama, J. Ohtsuka, H. Funahashi, A. Imaoka, Y. Okada, and Y. Umesaki. 1998. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut. 43:71-78.
35. Rivera-Nieves, J., G. Bamias, A. Vidrich, M. Marini, T.T. Pizarro, M.J. McDuffie, C.A. Moskaluk, S.M. Cohn, and F. Cominelli. 2003. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology. 124:972-982.
36. Kosiewicz, M.M., C.C. Nast, A. Krishnan, J. Rivera-Nieves, C.A. Moskaluk, S. Matsumoto, K. Kozaiwa, and F. Cominelli. 2001. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J. Clin. Invest. 107:695-702.
37. Takedatsu, H., K. Mitsuyama, S. Matsumoto, K. Handa, A. Suzuki, H. Takedatsu, H. Funabashi, Y. Okabe, T. Hara, A. Toyonaga, and M. Sata. 2004. Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice. Eur. J. Immunol. 34:1561-1569.
38. Olson, T.S., G. Bamias, M. Naganuma, J. Rivera-Nieves, T.L. Burcin, W. Ross, M.A. Morris, T.T. Pizarro, P.B. Ernst, F. Cominelli, and K. Ley. 2004. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J. Clin. Invest. 114:389-398.
39. Marini, M., G. Bamias, J. Rivera-Nieves, C.A. Moskaluk, S.B. Hoang, W.G. Ross, T.T. Pizarro, and F. Cominelli. 2003. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. USA. 100:8366-8371.
40. Bamias, G., M. Marini, C.A. Moskaluk, M. Odashima, W.G. Ross, J. Rivera-Nieves, and F. Cominelli. 2002. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J. Immunol. 169:5308-5314.
41. Kozaiwa, K., K. Sugawara, M.F. Smith Jr., V. Carl, V. Yamschikov, B. Belyea, S.B. McEwen, C.A. Moskaluk, T.T. Pizarro, F. Cominelli, and M. McDuffie. 2003. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology. 125:477-490.
42. Sugawara, K., T.S. Olson, C.A. Moskaluk, B.K. Stevens, S. Hoang, K. Kozaiwa, F. Cominelli, K.F. Ley, and M. McDuffie. 2005. Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. Gastroenterology. 128:351-360.
43. Burns, R.C., J. Rivera-Nieves, C.A. Moskaluk, S. Matsumoto, F. Cominelli, and K. Ley. 2001. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology. 121:1428-1436.
44. El Asmar, R., P. Panigrahi, P. Bamford, I. Berti, T. Not, G.V. Coppa, C. Catassi, and A. Fasano. 2002. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology. 123:1607-1615.
45. Meddings, J.B., and I. Gibbons. 1998. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology. 114:83-92.
46. Korngold, B., and J. Sprent. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J. Exp. Med. 148:1687-1698.
47. Neutra, M.R., N.J. Mantis, and J.P. Kraehenbuhl. 2001. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2:1004-1009.
48. Bruewer, M., A. Luegering, T. Kucharzik, C.A. Parkos, J.L. Madara, A.M. Hopkins, and A. Nusrat. 2003. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171:6164-6172.
49. Madsen, K.L., D. Malfair, D. Gray, J.S. Doyle, L.D. Jewell, and R.N. Fedorak. 1999. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm. Bowel Dis. 5:262-270.
50. Dvorak, A.M., and G.R. Dickersin. 1980. Crohn's disease: transmission electron microscopic studies. I. Barrier function. Possible changes related to alterations of cell coat, mucous coat, epithelial cells, and Paneth cells. Hum. Pathol. 11:561-571.
51. Scott, K.G., J.B. Meddings, D.R. Kirk, S.P. Lees-Miller, and A.G. Buret. 2002. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology. 123:1179-1190.
52. Kucharzik, T., S.V. Walsh, J. Chen, C.A. Parkos, and A. Nusrat. 2001. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am. J. Pathol. 159:2001-2009.
53. Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
54. Boughton-Smith, N.K.,J.L. Wallace, and B.J. Whittle. 1988. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions. 25:115-123.